UNSPSC 51422107: Meprednisone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H28O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67U96J8P35, chemically known as 17, 21-dihydroxy-16.beta.-methylpregna-1,4-diene-3,11,20-trione but generally known as meprednisone, which bears US NIH Compound Identifier 4063. European Medicines Agency schedules Meprednisone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08756MIG. The term MEPREDNISONE is an International Non-Proprietary Name.

UNSPSC 51422107 Meprednisone is a Commodity code that appears to capture pharmaceutical products, though the recent state and local opportunities tagged under it do not align with meprednisone specifically. The Seminole County, Florida IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs, indicate the code is being applied broadly to pharmaceutical procurement rather than to a single active pharmaceutical ingredient. State and local governments buying under this code are acquiring pharmaceutical supplies and exploring pharmacy benefit management structures to support public health initiatives, emergency response, and employee health programs. Issuing bodies include county health departments and state human services commissions.

Seminole County, Florida posted the most recent concrete opportunity—IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with a response deadline of July 26, 2026, and quarterly deliveries required to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor intelligence on direct-to-manufacturer prescription contracting capabilities outside traditional pharmacy benefit manager and group purchasing organization channels, signaling the state's exploration of alternative pharmacy procurement models. Geographic activity centers on Florida and Texas; the code shows limited recent traceable activity beyond these two states.